“Unlocking the Power of Precision Oncology: Guardant Health’s Groundbreaking Data at ASCO GI”
Guardant Health Presents Data on Precision Oncology Tools at ASCO GI Symposium Introduction Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has announced that it will be presenting data on the benefits of its precision oncology tools at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) in San Francisco from…